# ERAP2

Source: https://onco.cc/targets/erap2/  
OnCo record `erap2` (Target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

ERAP2 trims protein fragments before loading onto class I HLA. More trimming does not guarantee more useful display.

## Summary

ERAP2 is an endoplasmic reticulum aminopeptidase involved in shaping peptides available for class I HLA. ERAP1 and ERAP2 have complementary substrate preferences in human biochemical experiments. Trimming can produce an appropriate peptide or remove a potentially useful one; abundance of the enzyme is not a universal measure of tumour targetability. Natural display, receptor recognition and treatment benefit remain separate questions.

## Fields

- Kind: Target
- Last checked: 2026-11-09
- Symbol: ERAP2
- Class: enzyme
- Biology: ERAP2 is an endoplasmic reticulum aminopeptidase involved in shaping peptides available for class I HLA. ERAP1 and ERAP2 have complementary substrate preferences in human biochemical experiments.

## Notes

- This record describes antigen-processing biology. It does not establish an approved drug, a clinical selection threshold or a tumour-specific vulnerability.

## Sources

- UniProt Q6P179: reviewed human ERAP2 protein: https://www.uniprot.org/uniprotkb/Q6P179/entry
- Primary antigen-processing experiment (PubMed 15908954): https://pubmed.ncbi.nlm.nih.gov/15908954/
- HGNC ERAP2 approved gene identity: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:29499

## Connected records

- targets: [ERAP1](https://onco.cc/targets/erap1/)
- terms: [Antigen-processing machinery (APM)](https://onco.cc/terms/antigen-processing-machinery/), [HLA (human leukocyte antigen) and MHC](https://onco.cc/terms/hla/)

---
JSON: https://onco.cc/api/v1/entities/erap2.json